Infliximab and Tofacitinib Attenuate Neutralizing Antibody Responses Against SARS-CoV-2 Ancestral and Omicron Variants in Inflammatory Bowel Disease Patients After 3 Doses of COVID-19 Vaccine

Autor: Zhigang Liu, James L. Alexander, Kathy Weitung Lin, Tariq Ahmad, Katrina M. Pollock, Nick Powell, Kaixing Le, Xin Zhou, Hajir Ibraheim, Sulak Anandabaskaran, Aamir Saifuddin, Leon R. McFarlane, Nikhil Anand, Laura Constable, Rocio Castro Seoane, Andrea D’Mello, Sharmili Balarajah, Lucy C. Hicks, Horace R.T. Williams, Jonathan W. Lo, Ailsa L. Hart, Daniel M. Altmann, Rosemary J. Boyton, Julian P. Teare, Rachel Nice, Claire Bewshea, James R. Goodhand, Nicholas A. Kennedy, Anna Barnes, John Kirkwood, Marian Parkinson, Helen Gardner-Thorpe, Charlie W. Lees, Gareth R. Jones, Kate Covil, Lauranne Derikx, Francesca Fiorentino, Peter M. Irving, Miles Parkes, Rachel Linger, Klaartje Kok, Irish Lee, Bessie Cipriano, Kamal V. Patel, Shaji Sebastian, Alexandra J. Kent, Ijeoma Chukwurah, Sulaimaan Haq, Parita Shah, Stephanie Wilken-Smith, Anitha Ramanathan, Mikin Patel, Lidia Romanczuk, Rebecca King, Jason Domingo, Bridget Knight, Djamila Shamtally, Vivien Mendoza, Joanne Sanchez, Hannah Stark, Louise Bee, Charmaine Estember, Darcy Watkins, Sam Stone, Beatriz Gros Alcalde, Giuseppe Ruocco, Manisha Baden, Graham Cooke, Evgenia Kourampa, Ciro Pasquale, Elena Robisco-Diaz, Suhaylah Bhatti

Publikováno v: Gastroenterology, 164, 2, pp. 300-303.e3
Gastroenterology, 164, 300-303.e3

Contains fulltext : 291656.pdf (Publisher’s version ) (Open Access)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::157731aa6412cb6ad216dbf0adf0dca5